Sodium and potassium intake in rheumatoid arthritis: a systematic review of clinical studies with implications for disease-related outcomes
Rheumatology International · 01.04.2026 · 46 (4)
DOI: 10.1007/s00296-026-06104-5 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Rheumatology International, online erschienen am 01.04.2026. Verfasst von Panagiota Anyfanti und 10 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. panyfan@hotmail.com. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Potassium, Dietary, Sodium, Dietary, Cardiovascular Diseases. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aristotle University of Thessaloniki.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is characterized by immune-mediated inflammation resulting in excess cardiovascular disease (CVD) risk. Increased sodium, decreased potassium intake and their ratio have been acknowledged as CVD risk modifiers, while pathophysiological studies suggest a role in autoimmunity and inflammation. We aimed to review in a systematic manner the literature regarding the effects of dietary sodium, potassium intake and their ratio, on cardiovascular and disease-related outcomes in patients with RA. We performed a systematic literature search in Medline and Cochrane. Our research concluded to 1,283 patients (8 studies). Although not all studies coincide, most agree that increased dietary sodium and reduced dietary potassium intake are adversely associated with disease related (rheumatic and immunologic) outcomes. The ratio between sodium and potassium emerges a potential indicator of autoimmunity state that needs to be further balanced. Only 4 studies reported associations with cardiovascular outcomes in RA, particularly hypertension, although not consistently and none with hard CVD endpoints. These findings support that interventions promoting a poor in sodium and rich in potassium diet in RA may have beneficial effects in terms of autoimmunity regulation, suppression of inflammation and improvement in cardiovascular health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. panyfan@hotmail.com.
- 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Department of Basic and Clinical Pharmacology with Toxicology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
- Cardiology Department, Erasmus MC Thoraxcentrum, Rotterdam, ZH-Holanda, Netherlands.
- Independent researcher, Vancouver, BC, Canada.
- Fourth Department of Internal Medicine, Hippokration Hospital, Thessaloniki, Greece.
Förderung
- Aristotle University of Thessaloniki
Zitieren
APA
Anyfanti, P., Antza, C., Tragiannidis, K., Belančić, A., Şener, Y. Z., Faour, A. K., Ainatzoglou, A., Angeloudi, E., Chaida, E., Dimitroulas, T., & Kotsis, V. (2026). Sodium and potassium intake in rheumatoid arthritis: a systematic review of clinical studies with implications for disease-related outcomes. Rheumatology International, 46(4). https://doi.org/10.1007/s00296-026-06104-5
Vancouver
Anyfanti P, Antza C, Tragiannidis K, Belančić A, Şener YZ, Faour AK, et al. Sodium and potassium intake in rheumatoid arthritis: a systematic review of clinical studies with implications for disease-related outcomes. Rheumatology International. 2026;46(4). doi:10.1007/s00296-026-06104-5
BibTeX
@article{Anyfanti2026,
author = {Anyfanti, Panagiota and Antza, Christina and Tragiannidis, Konstantinos and Belančić, Andrej and Şener, Yusuf Ziya and Faour, Andrea Katrin and Ainatzoglou, Alexandra and Angeloudi, Elena and Chaida, Evangelia and Dimitroulas, Theodoros and Kotsis, Vasilios},
title = {Sodium and potassium intake in rheumatoid arthritis: a systematic review of clinical studies with implications for disease-related outcomes},
journal = {Rheumatology International},
year = {2026},
volume = {46},
number = {4},
doi = {10.1007/s00296-026-06104-5}
}
EUVIMED